Taiwan vs India: Generic Pharmaceutical Sourcing for ASEAN Markets
A practical comparison of quality, documentation, supply stability and pricing to help ASEAN importers make better decisions.
Taiwan vs India for ASEAN Generic Pharmaceutical Sourcing
Both Taiwan and India are major generic pharmaceutical sources for ASEAN. Here is a clear comparison:
Manufacturing Quality - Taiwan: Almost all exporters are PIC/S GMP certified with high consistency. - India: Large manufacturers are excellent, but quality varies significantly among smaller suppliers.
Regulatory Documentation - Taiwan: Strong ACTD dossier readiness and good English documentation. - India: Documentation often requires more work from the importer.
Supply Stability - Taiwan: Better suited for hospital and government tenders due to reliable batch consistency. - India: Excellent for very large volumes, but occasional supply disruptions occur with mid-tier suppliers.
Price India usually offers lower prices, but when factoring in registration success rate, lead time risk, and supply reliability, Taiwan often provides better total value for critical products.
Recommendation Choose Taiwan for high-value, hospital-grade, or time-sensitive products. Consider India for high-volume, low-margin commodities.
Need a Taiwan Generic Medicine Supplier?
Our team supports pharmaceutical importers with end-to-end sourcing and registration planning.
Submit a Product Inquiry →Quick response within 24 hours